Login
Subscribedrug development
New Strategies for Repurposing Existing Therapies
The Scientist’s Creative Services Team | Aug 10, 2023 | 1 min read
Drug repurposing uses existing drugs beyond the scope in which they were originally approved by the Food and Drug Administration.
Simplifying the Search for Drug Targets
Aparna Nathan, PhD | Aug 1, 2023 | 3 min read
A new machine learning model promises fast prediction of drug-target interactions.
Introducing GMP-Grade Recombinant Cytokines for Stem Cell Research
The Scientist’s Creative Services Team and Sino Biological | 3 min read
Cutting edge technology delivers cytokines with high purity, high bioactivity, high batch-to-batch consistency, and high stability.
Searching for a Direct Route to Multiple Sclerosis Treatment
Deanna MacNeil, PhD | Jul 17, 2023 | 3 min read
Researchers created a new high-throughput tool to hunt for therapies that remyelinate the nervous system.
Self-Charging Battery Battles Tumors in Mice
Natalia Mesa, PhD | Apr 4, 2023 | 3 min read
A battery that charges itself in salty fluids starves tumors of oxygen, helping improve some drugs treat cancer, a study finds.
Affinity versus Avidity: Differentiating Between Binding Phenomena
The Scientist’s Creative Services Team | 1 min read
In this webinar, Tim Heiseler will discuss the importance of assay design when measuring binding kinetics and affinity values, as well as strategies to mitigate avidity effects.
Diving Deeper into Tissue Samples with Spatial Context
Canopy Biosciences | Mar 15, 2023 | 1 min read
Scientists developed a standardized multiplex immunohistochemistry and RNA in situ hybridization protocol using ChipCytometryTM.
Hormone Sobers Up Drunken Mice: Study
Alejandra Manjarrez, PhD | Mar 8, 2023 | 3 min read
A hormone naturally induced by alcohol consumption accelerates the recovery of mice after binge drinking by activating neurons involved in arousal and alertness.
Precision Medicine-Based Biomarkers for Traumatic Brain Injury
The Scientist’s Creative Services Team | 1 min read
In this webinar, Dr. Kevin Wang will discuss a precision medicine approach for treating traumatic brain injury which uses phenotype biomarkers to monitor disease course and develop novel therapies.
Psychedelics Slip Past Cell Membranes When Treating Depression
Alejandra Manjarrez, PhD | Feb 24, 2023 | 4 min read
The antidepressant properties of hallucinogenic drugs may stem from their ability to bind to intracellular serotonin receptors, a study suggests.
Researchers Make Alternatives to Shark-Sourced Vaccine Ingredient
Natalia Mesa, PhD | Feb 22, 2023 | 3 min read
Synthetic variations of squalene, which is used to boost immune responses, could make vaccines more effective while reducing fisheries for struggling sharks.
The Scientist’s Journal Club: Infectious Diseases
The Scientist’s Creative Services Team | 1 min read
Scientists present the latest research on infection prevention and treatment, including COVID-19 and tropical infectious diseases.
RSV Vaccines That Work?
Rachael Moeller Gorman | Feb 16, 2023 | 10+ min read
Multiple candidates are in Phase 3 clinical trials for older adults and pregnant women, with some getting close to approval in the United States.
Fast-Acting Nonhormonal Male Birth Control Prevents Pregnancy in Mice
Katherine Irving | Feb 15, 2023 | 5 min read
The “on demand” drug immobilizes sperm rather than limit their production, preventing 100 percent of pregnancies in an experiment.
The Ins and Outs of LC-MS
Deanna MacNeil, PhD | 4 min read
From proteomics to pharmacokinetics, researchers turn to advances in liquid chromatography and mass spectrometry to identify and quantify components in different samples.
Connecting the Complexities of Heart Failure and Aging
Deanna MacNeil, PhD | Feb 13, 2023 | 3 min read
Researchers learned how IGFBP7, a senescence signaling protein and biomarker, promotes cardiac remodeling and cellular aging.
Viral Vector Platforms for Gene Therapy
The Scientist’s Creative Services Team | Feb 9, 2023 | 1 min read
In both the laboratory and clinic, scientists harness viral genetic transfer capabilities to develop gene therapies that modulate cellular function.
Starting with Human Cell Systems
The Scientist’s Creative Services Team | 1 min read
Xitiz Chamling shares how advances in human stem cell and gene editing technologies fuel his drive for better multiple sclerosis drug screening platforms.
Drugs Hitch a Ride on Algae for Targeted Delivery
Holly Barker, PhD | Feb 1, 2023 | 3 min read
A new microrobot uses algae to transport antibiotics into the lungs of mice with pneumonia.
Infographic: Algae Robots Transport Antibiotics to Infected Tissues
Holly Barker, PhD | Feb 1, 2023 | 1 min read
Microscopic algae dotted with drug-filled nanoparticles may offer a more effective means of treatment than traditional delivery methods.